Skip to main content
. 2018 Apr 13;13(4):e0195703. doi: 10.1371/journal.pone.0195703

Fig 2.

Fig 2

The U251 cells labeled by Fe3O4@Au-C225 composite targeted MNPs at the concentration of 0.01mg/mL, 0.05mg/mL and 0.1mg/mL (A); The MRI of the U251 cells labeled by Fe3O4@Au-C225 composite targeted MNPs (a), Fe3O4@Au composite MNPs (b), both Fe3O4@Au-C225 composite targeted MNPs and C225 (c)(B); The T2WI relaxation time of the U251 cells labeled by Fe3O4@Au-C225 composite targeted MNPs (a), Fe3O4@Au composite MNPs(b), both Fe3O4@Au-C225 composite targeted MNPs and C225(c)(*compared with the control group, P<0.05)(C).